Position in EXEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,632
+$346 QoQ
Shares Held
30
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#726
of 757 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MidFirst Bank holds $171,027 across 12 Biotechnology names. EXEL ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
138 | $68,548 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98 | $61,106 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
347 | $27,159 | |
| 4 | TECH |
BIO-TECHNE Corp
|
61 | $4,309 | |
| 5 | GMAB |
Genmab A/S
|
75 | $2,060 | |
| 6 | RPRX |
Royalty Pharma plc
|
34 | $1,906 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
30 | $1,632 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
46 | $1,627 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,632 | 30 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,286 | 30 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||